TriangleRadiation therapy (NCT05100095)
Radiation therapy trial for Merkel Cell Carcinoma (NCT05100095). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with Merkel-cell carcinoma without distant spread. Recent tumor removal or qualifying lymph-node procedures is required, depending on the radiation field. Previous radiation overlapping that field is excluded.
The idea: researchers test larger radiation doses per visit over a shorter course. Patients receive ten weekday treatments over two weeks, directed to the tumor bed, lymph nodes, or both. Immunotherapy is allowed but optional. Researchers track cancer control and side effects.
This phase 2 study plans 52 patients. Devarati Mitra leads at MD Anderson, Houston, the sole recruiting US site.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.